KYNTRA BIO Stock Price, News & Analysis
KYNB
NASDAQ
Company Description
Welcome to the overview page for KYNTRA BIO (KYNB), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$7.25
-9.94%
0.80
Last updated: February 24, 2026 at 15:59
-15.26%
Performance 1 year
$33.7M
4.0M
Latest News
SEC Filings
Financial Highlights
$29.6M
Revenue (TTM)
-$47.6M
Net Income (TTM)
$-0.48
-$138.0M
Operating Cash Flow
-160.6%
-507.8%
Upcoming Events
FEB
26
February 26, 2026
Marketing
Oppenheimer presentation
Virtual presentation at Oppenheimer 36th Annual Healthcare Life Sciences; webcast; replay on investor page for 90 days
MAR
11
March 11, 2026
Marketing
Leerink presentation
Presentation at Leerink Global Healthcare Conference in Miami; webcast; replay on investor page for 90 days; one-on-ones availab
JUL
01
July 1, 2026 - December 31, 2026
Clinical
Phase 2 monotherapy interim analysis
FG-3246 Phase 2 monotherapy interim analysis expected in 2H 2026; no date/webcast provided
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of KYNTRA BIO (KYNB)?
The current stock price of KYNTRA BIO (KYNB) is $8.05 as of February 23, 2026.
What is the market cap of KYNTRA BIO (KYNB)?
The market cap of KYNTRA BIO (KYNB) is approximately 33.7M. Learn more about what market capitalization means .
What is the revenue (TTM) of KYNTRA BIO (KYNB) stock?
The trailing twelve months (TTM) revenue of KYNTRA BIO (KYNB) is $29.6M.
What is the net income of KYNTRA BIO (KYNB)?
The trailing twelve months (TTM) net income of KYNTRA BIO (KYNB) is -$47.6M.
What is the earnings per share (EPS) of KYNTRA BIO (KYNB)?
The diluted earnings per share (EPS) of KYNTRA BIO (KYNB) is $-0.48 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of KYNTRA BIO (KYNB)?
The operating cash flow of KYNTRA BIO (KYNB) is -$138.0M. Learn about cash flow.
What is the profit margin of KYNTRA BIO (KYNB)?
The net profit margin of KYNTRA BIO (KYNB) is -160.6%. Learn about profit margins.
What is the operating margin of KYNTRA BIO (KYNB)?
The operating profit margin of KYNTRA BIO (KYNB) is -507.8%. Learn about operating margins.
What is the gross margin of KYNTRA BIO (KYNB)?
The gross profit margin of KYNTRA BIO (KYNB) is 47.5%. Learn about gross margins.
What is the current ratio of KYNTRA BIO (KYNB)?
The current ratio of KYNTRA BIO (KYNB) is 1.47, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the gross profit of KYNTRA BIO (KYNB)?
The gross profit of KYNTRA BIO (KYNB) is $14.1M on a trailing twelve months (TTM) basis.
What is the operating income of KYNTRA BIO (KYNB)?
The operating income of KYNTRA BIO (KYNB) is -$150.4M. Learn about operating income.